Skip to content

Hiroyuki Kamakura

3 papers in the library · 31 citations · publishing 2008

Papers

Sort Most recent Most cited

Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical Affairs Law in Japan, Part II: Color Test and TLC

YAKUGAKU ZASSHI June 1, 2008 Nahoko Uchiyama, Maiko Kawamura, Hiroyuki Kamakura et al. 17 citations

Many psychotropic substances are readily available in Japan via the Internet. To avoid the spread of drug abuse, some drugs have been controlled as designated substances (Shitei-Yakubutsu) in Japan since 2007 by the Pharmaceutical Affairs Law. Twenty-nine designated substances (classified as tryptamine, phenethylamine and piperazine types) were analyzed using color tests and TLC. The color...

[Analytical data of designated substances (Shitei-Yakubutsu) controlled by the Pharmaceutical Affairs Law in Japan, part I: GC-MS and LC-MS].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan June 1, 2008 Ruri Kikura-Hanajiri, Maiko Kawamura, Nahoko Uchiyama et al.

In the last 10 years, many analogs of narcotic substances have been widely distributed in Japan as easily available psychotropic substances and this has become a serious problem. They have been sold as video cleaners, incense and reagents via the Internet or in video shops. They are not controlled under the Narcotics and Psychotropics Control Law because their pharmacological effects have not...

[Authentication and ultra performance liquid chromatography (UPLC)/MS analysis of magic mint, Salvia divinorum and its related plants].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2008 Takuro Maruyama, Hiroyuki Kamakura, Ruri Kikura-Hanajiri et al. 14 citations

Ultra performance liquid chromatography (UPLC)/mass spectrometry (MS) analysis was performed to investigate whether commercial Salvia cultivars available in the Japanese market contain salvinorin A (1), which is an hallucinogen present in magic mint (Salvia divinorum) prior to the regulation of S. divinorum by the Japanese Pharmaceutical Affairs Law. In addition, a previously reported method to...